VPIM
Vanguard Personalized Indexing Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Sell |
21,123
-633
| -3% | -$4.06K | ﹤0.01% | 1692 |
|
|
2025
Q1 | $77K | Buy |
21,756
+4,032
| +23% | +$14.3K | ﹤0.01% | 1646 |
|
|
2024
Q4 | $67K | Buy |
17,724
+1,132
| +7% | +$4.28K | ﹤0.01% | 1664 |
|
|
2024
Q3 | $53.8K | Buy |
16,592
+4,851
| +41% | +$15.7K | ﹤0.01% | 1671 |
|
|
2024
Q2 | $22.3K | Buy |
+11,741
| New | +$22.3K | ﹤0.01% | 1642 |
|